New Data on 2 Alzheimer’s Drugs Alters Hope and Expectation

Solanezumab, from Eli Lilly, is getting another look for mild cases, and Biogen said data from a small group taking aducanumab showed mixed results. [Source]

Origin: nytimes.com

Category: Alzheimer's Disease

Topics: results, mixed, showed, aducanumab, taking, group, small, Biogen, cases, another, getting, Lilly, Solanezumab, Expectation, Alters, Drugs, Alzheimer’s

Source: http://rss.nytimes.com/c/34625/f/640350/s/48561f41/sc/15/l/0L0Snytimes0N0C20A150C0A70C230Cbusiness0Cnew0Edata0Eon0E20Ealzheimers0Edrugs0Ealters0Ehope0Eand0Eexpectation0Bhtml0Dpartner0Frss0Gemc0Frss/story01.htm